"esophageal foreign body" trang 5 - tải miễn phí từ tailieunhanh
TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma

TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma
9    87    0
Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): A multicenter observational study
10    44    0
The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy

The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
10    88    0
PIK3CA mutation is a favorable prognostic factor in esophageal cancer: Molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue

PIK3CA mutation is a favorable prognostic factor in esophageal cancer: Molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue
13    87    0
Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma

Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma
8    65    0
Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma

Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
8    44    1
The FREGAT biobank: A clinico-biological database dedicated to esophageal and gastric cancers

The FREGAT biobank: A clinico-biological database dedicated to esophageal and gastric cancers
12    83    1
Estimates and predictors of health care costs of esophageal adenocarcinoma: A population-based cohort study

Estimates and predictors of health care costs of esophageal adenocarcinoma: A population-based cohort study
19    42    1
Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the Creactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: A retrospective analysis

Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the Creactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: A retrospective analysis
8    88    1
Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya

Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya
8    82    1
Thoracoscopic and hand assisted laparoscopic esophagectomy with radical lymph node dissection for esophageal squamous cell carcinoma in the left lateral decubitus position: A single center retrospective analysis of 654 patients

Thoracoscopic and hand assisted laparoscopic esophagectomy with radical lymph node dissection for esophageal squamous cell carcinoma in the left lateral decubitus position: A single center retrospective analysis of 654 patients
10    50    1
Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis

Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
13    40    1
Chemoradiation in elderly esophageal cancer patients: Rationale and design of a phase I/II multicenter study (OSAGE)

Chemoradiation in elderly esophageal cancer patients: Rationale and design of a phase I/II multicenter study (OSAGE)
8    77    1
Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma

Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma
11    47    1
Physical ExeRcise Following Esophageal Cancer Treatment (PERFECT) study: Design of a randomized controlled trial

Physical ExeRcise Following Esophageal Cancer Treatment (PERFECT) study: Design of a randomized controlled trial
9    59    1
A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma

A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma
11    75    1
Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma

Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma
7    47    1
Master techniques in surgery: Esophageal surgery - part 1

Master techniques in surgery: Esophageal surgery - part 1
234    59    1
Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: A retrospective cohort analysis

Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: A retrospective cohort analysis
9    66    1
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma

A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma
8    71    1